Background: A satisfactory biopsy determines the state-of-the-art management of lung cancer in this era of personalized medicine. This study aimed to investigate the suitability and efficacy of computed tomography (CT)-guided core needle biopsy in clinical management.
Methods: A cohort of 353 patients with clinically suspected lung cancer was enrolled in the study.